188 related articles for article (PubMed ID: 22260898)
1. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality.
Schwenzer NF; Stegger L; Bisdas S; Schraml C; Kolb A; Boss A; Müller M; Reimold M; Ernemann U; Claussen CD; Pfannenberg C; Schmidt H
Eur J Radiol; 2012 Nov; 81(11):3472-8. PubMed ID: 22260898
[TBL] [Abstract][Full Text] [Related]
2. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor imaging in a human PET/MR hybrid system.
Boss A; Kolb A; Hofmann M; Bisdas S; Nägele T; Ernemann U; Stegger L; Rossi C; Schlemmer HP; Pfannenberg C; Reimold M; Claussen CD; Pichler BJ; Klose U
Invest Radiol; 2010 May; 45(5):270-4. PubMed ID: 20351651
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI.
Stegger L; Martirosian P; Schwenzer N; Bisdas S; Kolb A; Pfannenberg C; Claussen CD; Pichler B; Schick F; Boss A
Acta Radiol; 2012 Nov; 53(9):1066-72. PubMed ID: 23117845
[TBL] [Abstract][Full Text] [Related]
6. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.
Boss A; Bisdas S; Kolb A; Hofmann M; Ernemann U; Claussen CD; Pfannenberg C; Pichler BJ; Reimold M; Stegger L
J Nucl Med; 2010 Aug; 51(8):1198-205. PubMed ID: 20660388
[TBL] [Abstract][Full Text] [Related]
7. High resolution BrainPET combined with simultaneous MRI.
Herzog H; Langen KJ; Weirich C; Rota Kops E; Kaffanke J; Tellmann L; Scheins J; Neuner I; Stoffels G; Fischer K; Caldeira L; Coenen HH; Shah NJ
Nuklearmedizin; 2011; 50(2):74-82. PubMed ID: 21286660
[TBL] [Abstract][Full Text] [Related]
8. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
[TBL] [Abstract][Full Text] [Related]
9. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
10. Impact of flexible body surface coil and patient table on PET quantification and image quality in integrated PET/MR.
Fürst S; Souvatzoglou M; Martinez-Möller A; Schwaiger M; Nekolla SG; Ziegler SI
Nuklearmedizin; 2014; 53(3):79-87. PubMed ID: 24658368
[TBL] [Abstract][Full Text] [Related]
11. Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.
Kinoshita M; Hashimoto N; Goto T; Yanagisawa T; Okita Y; Kagawa N; Kishima H; Tanaka H; Fujita N; Shimosegawa E; Hatazawa J; Yoshimine T
Neuroimage; 2009 Apr; 45(2):312-8. PubMed ID: 19111621
[TBL] [Abstract][Full Text] [Related]
12. The effect of MR surface coils on PET quantification in whole-body PET/MR: results from a pseudo-PET/MR phantom study.
Tellmann L; Quick HH; Bockisch A; Herzog H; Beyer T
Med Phys; 2011 May; 38(5):2795-805. PubMed ID: 21776816
[TBL] [Abstract][Full Text] [Related]
13. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH
Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750
[TBL] [Abstract][Full Text] [Related]
14. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
16. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
18. Analysis and correction of count rate reduction during simultaneous MR-PET measurements with the BrainPET scanner.
Weirich C; Brenner D; Scheins J; Besancon E; Tellmann L; Herzog H; Shah NJ
IEEE Trans Med Imaging; 2012 Jul; 31(7):1372-80. PubMed ID: 22374353
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous reconstruction of activity and attenuation for PET/MR.
Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
